Triptolide
- Generic Name
- Triptolide
- Drug Type
- Small Molecule
- Chemical Formula
- C20H24O6
- CAS Number
- 38748-32-2
- Unique Ingredient Identifier
- 19ALD1S53J
- Background
Triptolide has been used in trials studying the treatment of HIV, Crohn's Disease, Intestinal Diseases, Gastrointestinal Diseases, and Digestive System Diseases, among others.
- Indication
用于治疗银屑病（牛皮癣）。
Minnelide and Osimertinib for the Treatment of Advanced EGFR Mutated Non-Small Cell Lung Cancer
Phase 1
Recruiting
- Conditions
- Stage III Lung Cancer AJCC v8Unresectable Lung Non-Small Cell CarcinomaAdvanced Lung Non-Small Cell CarcinomaStage IVB Lung Cancer AJCC v8Stage IIIB Lung Cancer AJCC v8Stage IIIC Lung Cancer AJCC v8Stage IVA Lung Cancer AJCC v8Locally Advanced Lung Non-Small Cell CarcinomaStage IIIA Lung Cancer AJCC v8Stage IV Lung Cancer AJCC v8
- Interventions
- First Posted Date
- 2021-12-22
- Last Posted Date
- 2025-02-24
- Lead Sponsor
- City of Hope Medical Center
- Target Recruit Count
- 30
- Registration Number
- NCT05166616
- Locations
- 🇺🇸
City of Hope Medical Center, Duarte, California, United States
Safety and Efficacy of Triptolide Wilfordii in New Onset HIV-1 Infection
Phase 3
Completed
- Conditions
- HIV-infection/AIDS
- Interventions
- Drug: Placebo Oral Tablet
- First Posted Date
- 2018-01-18
- Last Posted Date
- 2022-04-08
- Lead Sponsor
- Peking Union Medical College Hospital
- Target Recruit Count
- 353
- Registration Number
- NCT03403569
- Locations
- 🇨🇳
The Eighth People's Hospital of Guangzhou, Guangzhou, Guangdong, China
🇨🇳The Fourth Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China
🇨🇳Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, Fujian, China
Impact on T Cell Immune Activation and Inflammation of Triptolide Woldifii in HIV-infected Immunological Non-responders
- First Posted Date
- 2013-03-25
- Last Posted Date
- 2013-03-25
- Lead Sponsor
- LI Taisheng
- Target Recruit Count
- 150
- Registration Number
- NCT01817283
- Locations
- 🇨🇳
Peking Union Medical College Hospital, Beijing, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath